Transcriptional Circuitry in HGSOC: A Dynamic Three-State Model Informed by a Living Biobank of Purified Tumour Fractions
Bethany M. BarnesiD, Samantha LittleriD, Anthony TigheiD, Alicia EvansiD, James AltringhamiD, Louisa NelsoniD, I‐Hsuan LiniD, Robert David MorganiD, Joanne C. McGrailiD, Stephen S. TayloriD
Abstract
High-grade serous ovarian cancer (HGSOC) is a heterogeneous disease, but efforts to define transcriptional subtypes using bulk RNA sequencing have been confounded by the presence of non-malignant cells. As a result, it remains unclear whether tumour-cell-intrinsic states exist, and whether these represent stable disease subtypes or are dynamically remodelled during disease progression and treatment. Here, we address this question using a living biobank of patient-derived ovarian cancer models (OCMs) cultured as purified tumour-cell populations under uniform conditions. RNA sequencing followed by unsupervised non-negative matrix factorisation (NMF) revealed a robust, hierarchical architecture comprising three core tumour-cell-intrinsic subtypes: the Alpha cluster, marked by cell-cycle deregulation and E2F-driven replication stress; the Beta cluster, defined by tumour-cell-intrinsic immune mimicry and inflammatory signalling; and the Gamma cluster, characterised by epithelial identity, extracellular matrix engagement, and metabolic adaptation. At higher clustering resolution, a fourth cluster, Delta, emerged as a Gamma sub-lineage distinguished by a vesicle-oriented, neuronal-like secretory programme. By projecting cluster labels onto a subset of matched longitudinal OCMs using non-negative least squares, we show that while some tumours retain stable subtype identities, others display transcriptional plasticity, including transitions from epithelial-like Gamma states to more proliferative or secretory phenotypes. Together, these findings define the core architecture and dynamic potential of tumour-cell-intrinsic transcriptional states within HGSOC, thereby bridging legacy bulk classifications with emerging single-cell insights, establishing a framework for more precise patient stratification.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transcriptomic subtypes in high-grade serous ovarian cancer are driven by tumor cellular composition
Stephanie Tanis, Manoel E. Lixandrão, … Natalie R. Davidson·bioRxiv·Apr 21, 2026
- Multi-omic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma
L. Geistlinger, S. Oh, … L. Waldron·bioRxiv·Jun 12, 2020
- Deconvolution reveals compositional differences in high-grade serous ovarian cancer subtypes
Ariel A. Hippen, Natalie R. Davidson, … Casey S. Greene·bioRxiv·Jun 14, 2023
- Classification of ovarian cancer cell lines using transcriptional profiles defines the five major pathological subtypes
B. Barnes, L. Nelson, … S. S. Taylor·bioRxiv·Jul 14, 2020
- A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high grade serous ovarian cancer
P. Lo Riso, C. E. Villa, … G. Testa·bioRxiv·Nov 30, 2018
- The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells
Z. Hu, M. Artibani, … A. A. Ahmed·bioRxiv·Jun 17, 2019